Embry : Supplemental Announcement

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

EMBRY HOLDINGS LIMITED

安莉芳控股有限公司

(incorporated in the Cayman Islands with limited liability)

(Stock Code: 1388)

SUPPLEMENTAL ANNOUNCEMENT

This announcement is made by Embry Holdings Limited (the "Company", together with its subsidiaries, the "Group") pursuant to Rule 13.09(1) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

Reference is made to the announcement of the Company dated 27 April 2021 in relation to (i) positive profit alert; and (ii) sales update for the Q1 Period (the "Announcement"). Capitalised terms used in this announcement shall have the same meanings as those defined in the Announcement unless otherwise stated.

The Board would like to clarify that, based on the information currently available to the Company and the preliminary assessment of the unaudited consolidated management accounts of the Group for the Q1 Period, it is expected that the Group will record a net profit of approximately HK$30 million for the Q1 Period, as compared to the net loss position for the corresponding period in 2020.

The information contained in this announcement is only based on the Board's preliminary assessment after reviewing the unaudited consolidated management accounts of the Group for the Q1 Period. The Group's half year results are subject to review by the Board, the audit committee of the Board and the Company's independent auditor. Therefore, the actual results of the Group for the six months ending 30 June 2021 may differ from the information contained in this announcement.

Shareholders of the Company and potential investors are advised to exercise caution when dealing in the shares of the Company.

On Behalf of the Board of

Embry Holdings Limited

Cheng Man Tai

Chairman

Hong Kong, 30 April 2021

As at the date of this announcement, the Board comprises five executive Directors, namely Mr. Cheng Man Tai (Chairman), Ms. Cheng Pik Ho Liza (Chief Executive Officer), Madam Ngok Ming Chu, Mr. Cheng Chuen Chuen and Ms. Lu Qun; and three independent non-executive Directors, namely Mr. Lau Siu Ki, Mr. Lee Kwan Hung and Prof. Lee T. S.